Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.
Speaker of the House Mike Johnson says releasing the ethics committee report on the Florida lawmaker would set "a terrible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback